Clinical trial for Healthy Adults
Official title A Study to Learn About mRNA Vaccines Against Influenza in Adults
ClinicalTrials.gov ID: NCT07431853
What this study is testing
What is Vaccine Candidate #1?
An investigational mRNA-based influenza vaccine being studied for safety and immune response in healthy adults.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study looks at how safe the vaccine is and whether it triggers an immune response against the flu virus.
- Who it's for
- Healthy adults aged 18 or older.
- What's involved
- Participants receive one arm shot of either the experimental mRNA vaccine or a standard flu vaccine, have blood drawn at three visits, and a nasal swab at the first visit.
- Time commitment
- The study lasts about six months with at least three site visits.
- Phase 2: a mid-size study of how well it works
- Time commitment: about 6 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Healthy and medically stable participants who are determined by medical history, physical examination (if clinically required), and clinical judgment...
You likely can't join if
- Tested positive for influenza ≤5 months (150 days) prior to Visit 1 (Day 1).
- Vaccination with any investigational or licensed influenza vaccine ≤5 months (150 days) before Visit 1 (Day 1).
- Receipt of antiviral therapies for influenza (eg, Tamiflu) ≤5 months (150 days) prior to Visit 1 (Day 1).
The study team makes the final eligibility decision.
Where it is enrolling
- Mobile, Alabama, United States
- Walnut Creek, California, United States
- Milford, Connecticut, United States
- Washington D.C., District of Columbia, United States
- Hialeah, Florida, United States
- Miami Lakes, Florida, United States
- Stockbridge, Georgia, United States
- Honolulu, Hawaii, United States
- Kansas City, Missouri, United States
- Rochester, New York, United States
- Philadelphia, Pennsylvania, United States
- Mesquite, Texas, United States
- Tomball, Texas, United States
- Salt Lake City, Utah, United States
- Charlottesville, Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Mobile, Alabama, United States; Walnut Creek, California, United States; Milford, Connecticut, United States; Washington D.C., District of Columbia, United States; Hialeah, Florida, United States; Miami Lakes, Florida, United States and 9 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.